Crowdonomics
WatchlistPortfolio
This isn’t HeartSciences Inc.’s most recent raise. Private · Common Stock · Jul 2026 (Closed) is more current.View latest round
HeartSciences Inc.

Reg A+ · Equity · Mar 2025

OpenReg A+Equity
via Digital Offering LLC · last checked Aug 16, 2026
Raised
$0 / $15M max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2023 · hover for source
$5K
−$6.4M
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$5,150
Cost of goods sold
$2,796
Gross margin
46%
Net income
-$6,354,290
Balance sheet
Cash
$1,660,467
Accounts receivable
$0
Total assets
$3,287,233
Short-term debt
$500,000
Long-term debt
$2,416,270
Total liabilities
$3,056,676
Other
Headcount
15

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Apr 10, 2026
    Post-qualification amendment — offering terms unchanged
    Form 1-A POS on EDGAR ↗
  2. Mar 3, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$4.9M
Price / share$3.50
Shares offered4,285,714

Estimated, not stated: $3.50 × 1,387,316 securities outstanding.

Offering details

Target—
Max$15,000,000
Min investment—
OpenedMar 10, 2025
Deadline—
Days active579

Links & provenance

SEC filing
Source: SEC EDGAR
0001213900-25-012899
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.